GeneDx Holdings Future Growth
Future criteria checks 1/6
GeneDx Holdings is forecast to grow earnings and revenue by 24.8% and 14.4% per annum respectively while EPS is expected to grow by 36.3% per annum.
Key information
24.8%
Earnings growth rate
36.3%
EPS growth rate
| Healthcare earnings growth | 16.3% |
| Revenue growth rate | 14.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 22 Apr 2024 |
Recent future growth updates
Recent updates
Further Upside For GeneDx Holdings Corp. (NASDAQ:WGS) Shares Could Introduce Price Risks After 42% Bounce
Apr 24
GeneDx Holdings Corp. (NASDAQ:WGS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$9.13
Feb 23The Market Lifts GeneDx Holdings Corp. (NASDAQ:WGS) Shares 107% But It Can Do More
Feb 22Improved Revenues Required Before GeneDx Holdings Corp. (NASDAQ:WGS) Stock's 56% Jump Looks Justified
Dec 20Analyst Forecasts Just Became More Bearish On GeneDx Holdings Corp. (NASDAQ:WGS)
Nov 02Not Many Are Piling Into GeneDx Holdings Corp. (NASDAQ:WGS) Stock Yet As It Plummets 49%
Nov 01Sema4 names Kevin Feeley as CFO
Aug 26Things Look Grim For Sema4 Holdings Corp. (NASDAQ:SMFR) After Today's Downgrade
Aug 20Sema4 Holdings Corp. (NASDAQ:SMFR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
Aug 19Sema4 Q2 2022 Earnings Preview
Aug 12Sema4 Holdings, Big Data For Precision Medicine Solutions
Jul 18Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 316 | N/A | N/A | N/A | 2 |
| 12/31/2025 | 264 | -107 | N/A | N/A | 4 |
| 12/31/2024 | 226 | -136 | N/A | N/A | 4 |
| 12/31/2023 | 203 | -176 | -186 | -180 | N/A |
| 9/30/2023 | 206 | -459 | -221 | -215 | N/A |
| 6/30/2023 | 236 | -494 | -272 | -262 | N/A |
| 3/31/2023 | 224 | -533 | -304 | -293 | N/A |
| 12/31/2022 | 235 | -549 | -333 | -319 | N/A |
| 9/30/2022 | 231 | -280 | -326 | -306 | N/A |
| 6/30/2022 | 191 | -170 | -308 | -289 | N/A |
| 3/31/2022 | 202 | -131 | -249 | -230 | N/A |
| 12/31/2021 | 212 | -245 | -211 | -190 | N/A |
| 9/30/2021 | 218 | -331 | -181 | -157 | N/A |
| 6/30/2021 | 214 | -420 | -140 | -114 | N/A |
| 3/31/2021 | 197 | -406 | -144 | -113 | N/A |
| 12/31/2020 | 179 | -241 | -125 | -93 | N/A |
| 12/31/2019 | 196 | -33 | -34 | -19 | N/A |
| 12/31/2018 | 133 | -27 | -29 | -25 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WGS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: WGS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: WGS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: WGS's revenue (14.4% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: WGS's revenue (14.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if WGS's Return on Equity is forecast to be high in 3 years time